Betta Pharmaceuticals 贝达药业
19 significant filings since 31 May 2026: 6 on share pledge, 8 on equity incentive and 1 on guarantee or financial assistance, and 4 other kinds. The latest, on 31 Aug 2026: 关于股东股份质押变动的公告. On 22 Jul 2026 the company said it expects net profit for the period ending 30 Jun 2026 to rise by 120.00% to 180.00% from the same period a year earlier.
自 31 May 2026 起有 19 份重大公告：share pledge 6 份、equity incentive 8 份、guarantee or financial assistance 1 份，另有 4 类。最新一份（31 Aug 2026）：关于股东股份质押变动的公告。22 Jul 2026 公司预告截至 30 Jun 2026 的净利润较上年同期上升 120.00% 至 180.00%。
| FY2026 | FY2027 | |
|---|---|---|
| Now 当前 | 1.37 | 1.76 |
| 7 days ago | 1.37 | 1.76 |
| 30 days ago | 1.37 | 1.76 |
| 60 days ago | 1 broker | 1 broker |
| 90 days ago | 1 broker | 1 broker |
Consensus is the median of each broker's latest forecast from the 120 days before each date. With fewer than 3 brokers, the broker count is shown. 一致预期为各券商在该日期前 120 天内最新预测的中位数；不足 3 家时显示券商数。
Consensus moved from 1.67 in Sep 2024 to 1.37 in Sep 2026 (-17.7%). 一致预期从 Sep 2024 的 1.67 变为 Sep 2026 的 1.37 (-17.7%)。 The shaded band runs from the lowest to the highest broker forecast.
| FY2026 | FY2027 | |
|---|---|---|
| Last 30 days | ▲ 0 ▼ 0 = 0 | ▲ 0 ▼ 0 = 0 |
| Last 90 days | ▲ 1 ▼ 2 = 0 | ▲ 1 ▼ 2 = 0 |
Each broker's latest forecast is compared with its previous forecast for the same year. A move within 0.5% counts as unchanged. 每家券商的最新预测与其对同一年度的上一次预测比较，变动在 0.5% 以内视为不变。
A surprise needs at least 3 brokers forecasting in the 120 days before the filing. FY2025 had 0 and FY2024 had 0. 惊喜幅度需公告前120天内至少3家券商预测；FY2025仅0家；FY2024仅0家。